SK

Shashi Kant Mishra

Active Director Director DIN 10832161
DIN 10832161 First appointment Nov 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shashi Kant Mishra

Data last updated:

Shashi Kant Mishra is a Director at Meadhope Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10832161
Primary Designation Director
Industry Paper
First Appointment 08 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meadhope Pharma Private Limited U21001DL2024PTC438557
Director08 Nov 20242024Active

Board colleagues of Shashi Kant Mishra

NameDINCompanyDesignation
Arti Mishra10989342Meadhope Pharma Private LimitedDirector
Shyam Dev10832162Meadhope Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Meadhope Pharma Private Limited
Premium access

Shareholding and investment profile for Shashi Kant Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashi Kant Mishra

Shashi Kant Mishra currently holds 1 directorship: Meadhope Pharma Private Limited (Director, since 08 Nov 2024).

Shashi Kant Mishra was first appointed on 08 Nov 2024 as Director at Meadhope Pharma Private Limited.

The current boards of Shashi Kant Mishra's companies include Arti Mishra (Meadhope Pharma Private Limited), Shyam Dev (Meadhope Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available